Approval · Notice of Compliance 3458 · 2003
PEGASYS: Notice of Compliance 3458
Issued August 13, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3458
- Date
- August 13, 2003
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Biological response modifier
Products in this notice
Medicinal ingredients
- PEGINTERFERON ALFA-2A 180 MCG per ML
- PEGINTERFERON ALFA-2A 180 MCG per 0.5ML